Abdel-Rahman EM, Hayes JS, Balogun RB. Therapeutic plasma exchange in the elderly: experience at a tertiary center. J Clin Apher. 2012;27:108-11.
Bajwa A, Huang L, Ye H, Dondeti K, Song S, Rosin DL, Lynch KR, Lobo PI, Li L, Okusa MD. Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J. Immunol. 2012;189:2584-96.
Balogun RA, Abdel-Rahman EM, Balogun SA, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Kalantar-Zadeh K, Kovesdy CP. Association of depression and antidepressant use with mortality in a large cohort of patients with nondialysis-dependent CKD. Clin J Am Soc Nephrol. 2012;7:1793-800.
Balogun SA, Balogun RA, Abdel-Rahman EM. Functional impairment in elderly patients with chronic kidney disease. In: Abdel-Rahman EM, Balogun RA, editors. Functional impairment: management, types and challenges. New York: Nova Science Publishers; 2012. p. 1-13.
Flohr TR, Bonatti H, Hranjec T, Keith DS, Lobo PI, Kumer SC, Schmitt TM, Sawyer RG, Pruett TL, Roberts JP, Brayman KL. Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease. J Surg Res. 2012;176(2):629-38.
Ge Y, Brown MG, Wang H, Fu SM. Genetic approach to study lupus glomerulonephritis. In: Perl A, editor. Autoimmunity: methods and protocols. Series: Methods in Molecular Biology. New York: Humana Press/Springer; 2012. p. 271-90.
Ju ST, Sharma R, Gaskin F, Fu SM. IL-2 controls trafficking receptor gene expression and Th2 response for skin and lung inflammation. Clin Immunol. 2012;145(1):82-8.
Kalantari K, Seliger S. Stroke symptoms signal worse outcomes in patients with end-stage renal disease. Neurology. 2012 Sep 4;79(10):960-1.
Kinsey GR, Huang L, Jaworska K, Khutsishvili K, Becker DA, Ye H, Lobo PI, Okusa MD. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol. 2012;23(9):1528-37.
Kinsey GR, Okusa MD. Role of leukocytes in the pathogenesis of acute kidney injury. Crit Care. 2012;16:214.
Lentine KL, Costa SP, Weir M, Robb JF, Fleisher L, Kasiske BK, Carithers RL, Ragosta, Bolton K, Auerbach AD, Eagle KA. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation. 2012;126:617-63.
Li L, Huang L, Ye H, Song SP, Bajwa A, Lee SJ, Moser EK, Jaworska K, Kinsey GR, Day YJ, Linden J, Lobo PI, Rosin DL, Okusa MD Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J Clin Invest. 2012;122:3931-42..
Relia N, Gokden N, Kulshrestha S, Swaminathan S. Monoclonal cryoglobulinemia, livedo reticularis, and renal failure. Kidney Int. 2012 Jul;82(1):118.
Rosin DL, Okusa MD. Dying cells and extracellular histones in AKI: beyond a NET effect? J Am Soc Nephrol. 2012;23(8):1275-7.
Scindia Y, Nackiewicz D, Dey P, Szymula A, Bajwa A, Rosin DL, Bolton WK, Okusa MD, Deshmukh U, Bagavant H. Activated CD4+ T cells target mesangial antigens and initiate glomerulonephritis. Nephron Exp Nephrol. 2012;121(1-2):e1-9.
Turkmen K, Erdur FM, Guney I, Gaipov A, Turgut F, Altintepe L, Saglam M, Tonbul HZ, Abdel-Rahman EM. Sleep quality, depression, and quality of life in elderly hemodialysis patients. Int J Nephrol Renovasc Dis. 2012;5:135-42.
Woywodt A, Gerdes S, Ahl B, Erdbruegger U, Haubitz M, Weissenborn K. Circulating endothelial cells and stroke: influence of stroke subtypes and changes during the course of disease. J Stroke Cerebrovasc Dis. 2012;21:452-8.
Selected Publications 2013
Abdel-Rahman EM, Balogun RA. Therapeutic apheresis in the elderly: an update. J Clin Apher. 2013;28:84-6.
Arogundade FA, Sanusi AA, Akinbodewa AA, Hassan MO, Omotosho BO, Balogun RA, Akinsola A. Filter membrane-based automated therapeutic plasma exchange: a report of two cases from Nigeria. J Clin Apher. 2013;28:78-83.
Bowman BT, Bernhard MR, Ibidapo AA, Okusa MD. Acute kidney injury due to ‘coral reef syndrome’. Kidney Int. 2013;83:182.
Bowman BT, Kleiner A, Bolton WK. Comanagement of diabetic kidney disease by the primary care provider and nephrologist. Med Clin North Am. 2013;97:157-73.
Chang J, Ma JZ, Zeng Q, Cechova S, Gantz A, Nievergelt C, O’Connor D, Lipkowitz M, Le TH. Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK). Am J Physiol Renal Physiol. 2013;304(4):F348-55.
Dolina JS, Sung SS, Novobrantseva TI, Nguyen TM, Hahn YS. Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-mediated Hepatic Antiviral Immunity. Mol Ther Nucleic Acids. 2013;2:e72.
Kalantari K, Chang JN, Ronco C, Rosner MH. Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int. 2013;83(6):1017-28.
Le TH, Crowley SD, Gurley SB, Coffman TM. The renin-angiotensin-aldosterone systems: renal mechanisms and circulatory homeostasis. In: Alpern RJ, Moe OW, Caplan M. Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology. 5th ed. New York: Academic Press/Elsevier Inc.; 2013. p. 427-50.
Lee HC, Sung SS, Krueger PD, Jo YA, Rosen HR, Ziegler SF, Hahn YS. Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes. Hepatology. 2013;57:1314-24.
Lewis JE, Fu SM, Gaskin F. Autoimmunity, end organ damage and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus. Discov Med 2013;15:85-92.
McCullough PA, Bouchard J, Waikar SS, Siew ED, Endre ZH, Goldstein SL, Koyner JL, Macedo E, Doi K, Di Somma S, Lewington A, Thadhani R, Chakravarthi R, Ice C, Okusa MD, Duranteau J, Doran P, Yang L, Jaber BL, Meehan S, Kellum JA, Haase M, Murray PT, Cruz D, Maisel A, Bagshaw SM, Chawla LS, Mehta RL, Shaw AD, Ronco C. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:5-12.
Nandula SR, Dey P, Corbin KL, Nunemaker CS, Bagavant H, Deshmukh US. Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling. J Oral Pathol Med. 2013;42:66-72.
Nishio A, Chhatkuli BP, Ma JZ, Kalantari K. Higher doses of erythropoietin-stimulating agents and hyporesponsiveness to their effects are associated with increased mortality among prevalent hemodialysis patients. Blood Purif. 2013;36:29-36.
Nishio-Lucar A, Balogun RA, Sanoff S. Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine. J Clin Apher. 2013;28:56-63.
Okusa MD, Jaber BL, Doran P, Duranteau J, Yang L, Murray PT, Mehta RL, Ince C. Physiological biomarkers of acute kidney injury: a conceptual approach to improving outcomes. Contrib Nephrol. 2013;182:65-81.
Soangra R, Lockhart T, Lach J, Abdel-Rahman EM. Effects of hemodialysis therapy in sit-to-walk characteristics in end stage renal disease patients. Ann Biochem Eng. 2013;41:795-805.
Szczerba BM, Rybakowska PD, Dey P, Payerhin KM, Peck AB, Bagavant H, Deshmukh US. Type I interferon receptor deficiency prevents murine Sjogren’s syndrome. J Dent Res. 2013;92:444-9.
Turgut F, Yesil Y, Balogun RA, Abdel-Rahman EM. Hypertension in the elderly: unique challenges and management. Clin Geriatr Med. 2013;29:593-609.
Winters JL, Balogun RA. The fifth annual therapeutic apheresis academy: continuity and changes. J Clin Apher. 2013;28:1-2.
Winters JL, Burgstaler EA, Gottschall JL, Balogun RA, Houghton JR, Lee WJ, Snyder EL. A multicenter evaluation of a new therapeutic plasma exchange procedure. Transfusion. 2013 Apr 15. doi: 10.1111/trf.12189.